Mounting competition in the sector and rising obesity have led the pharmaceutical company to start selling the drug directly ...

The Dow Jones Industrial Average (DJIA) took another leg lower on Monday, kicking off the new trading week with a fresh 1,000 ...

Note: Noom Med — Noom’s weight loss medication service — costs an additional ... fun game to me to log my food and then look at the charts and how the calories are divided into the green ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

Ozempic is a diabetes drug sometimes prescribed off-label for weight loss. (Off-label use means it’s prescribed for something other than what the FDA approved it for.) So there’s no set timefr ...

A study by Mass General Brigham found that taking the weight-loss drug semaglutide before bariatric surgery does not lead to better overall weight loss outcomes. The research suggests that ...

On today's Market Minute, Madison Mills examines the stories moving markets on Tuesday. Stellantis (STLA) shares are under ...

We are looking into a health alert, as the FDA has ruled compounded versions of popular drugs used for weight loss will no ...